Global Implantable Collamer Lens Market
Medical Equipment

Top Trends Driving Innovation and Change in the Implantable Collamer Lens Market: New Approvals And Innovations Transforming The Vision Correction Landscape

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has The Implantable Collamer Lens Market Size Shifted, And What Is the Outlook Through 2034?

The market for implantable collamer lenses has seen robust growth in the past few years. The market value, which stood at $19.53 billion in 2024, is projected to reach $20.91 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.10%. Factors contributing to this significant growth in the historical period include the amplified awareness of vision correction alternatives, the increase in acceptance of minimally invasive surgical procedures, the escalating prevalence of refractive errors, favorable reimbursement regulations in key areas, and greater investment in research within the field of ophthalmology.

Anticipations for strong expansion are seen within the implantable collamer lens market in the upcoming years, with predictions of reaching $27.25 billion by 2029 with a CAGR of 6.84%. The predicted growth within this timeframe can be associated with the increased demand for long-lasting vision correction alternatives, a rise in conditions such as myopia and astigmatism, a greater emphasis on patient-centric and personalized implants, an elder population requiring more eye care, and development of ambulatory surgery centers. In the forecast period, major trends to watch out for include AI integration into pre-surgery planning, creation of foldable and biocompatible lens materials, collaborations between product manufacturers and health service providers, technological improvements in lens materials and designs, and progress in implantable lens technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Implantable Collamer Lens Market?

The escalating incidences of vision impairments are anticipated to catalyze the implantable collamer lens market. Vision impairments, marked by a gradual depletion in visual acuity and ocular health, hinder clear sight. Factors such as an aging populace, prolonged screen exposure, and the increasing instances of conditions like myopia and age-related macular degeneration contribute to the spread of these disorders globally. Implantable Collamer Lenses (ICLs) provide a safe, reversible alternative to regular refractive surgeries like LASIK, effectively rectifying myopia, hyperopia, and astigmatism. For example, the World Health Organization revealed in a report from August 2023 that globally, more than 2.2 billion people are affected by near or distance vision impairment, from which 1 billion cases can either be prevented or are still not addressed. Furthermore, according to the UK Welsh Government in July 2023, about 1,563 new certificates of vision impairment (CVI) were released in 2021-22, an upsurge of 49.1% compared to the prior year. Consequently, the surge in vision impairments is propelling the implantable collamer lens market’s growth. Implications Of An Aging Populace On The Expansion Of The Implantable Collamer Lens Market

What Segment Types Define the Implantable Collamer Lens Market Structure?

The implantable collamer lens market covered in this report is segmented –

1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)

2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques

3) By Application: Myopia, Hyperopia, Astigmatism

4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User

Subsegments:

1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia

2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20840&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Implantable Collamer Lens Market?

North America was the largest region in the implantable collamer lens market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Implantable Collamer Lens Industry?

Key players in the implantable collamer lens (ICL) market are aiming to edge out competition by innovating lens technology and securing necessary approvals. The Implantable Collamer Lens is specifically crafted to rectify refractive vision issues and offers a less invasive remedy for myopia and astigmatism. For instance, the U.S. Food and Drug Administration (FDA) approved the EVO/EVO+ Visian Implantable Collamer Lens (EVO) developed by STAAR Surgical Company, a U.S. firm specializing in manufacturing and marketing implantable lenses and associated delivery systems for the eye, in April 2022. The approval was for the correction of myopia and myopia coupled with astigmatism. The EVO Visian ICL lens is made to rectify or lessen nearsightedness within the range of -3.0 D to -20.0 D and treat astigmatism from 1.0 D to 4.0 D.

View the full report here:

https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report

What Is the Definition of the Implantable Collamer Lens Market?

Implantable collamer lenses (ICLs), often referred to as implantable contact lenses, are refractive lens implants that are placed into the eye to treat various disorders. It works just like a contact lens, with the exception that it is surgically placed in front of your natural lens and behind the iris, the colored portion of the eye.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20840

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model